0000950170-24-080557.txt : 20240702
0000950170-24-080557.hdr.sgml : 20240702
20240702163214
ACCESSION NUMBER: 0000950170-24-080557
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Marc
CENTRAL INDEX KEY: 0001702265
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 241096077
MAIL ADDRESS:
STREET 1: 6310 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-06-28
false
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001702265
Wilson Marc
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD
SAN DIEGO
CA
92121
false
true
false
false
CFO
true
Common Stock
2024-06-28
4
M
false
32129
9.28
A
143221
D
Common Stock
2024-06-28
4
S
false
32129
43.61
D
111092
D
Stock option (Right to Buy)
9.28
2024-06-28
4
M
false
32129
0
D
2028-05-24
Common Stock
32129
19056
D
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.61 per share. The range of sales prices on the transaction date was $43.28 to $44.13 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Includes 462 shares acquired under the Issuer's Employee Stock Purchase Plan.
1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Marc Wilson
2024-07-02